Alexza’s Staccato® Nicotine Licensed to Cypress Bioscience
Alexza’s Staccato® Nicotine Licensed to Cypress Bioscience
MOUNTAIN VIEW, Calif., Aug. 26 /PRNewswire-FirstCall/ — Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. (Nasdaq: CYPB). The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a …
Read more on redOrbit
Related Reading:
If you enjoyed this post, make sure you subscribe to my RSS feed!





